Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension

Autor: Valentine Mismetti, Xavier Delavenne, David Montani, Souad Bezzeghoud, Olivier Delezay, Sophie Hodin, David Launay, Sylvain Marchand-Adam, Hilario Nunes, Edouard Ollier, Martine Reynaud-Gaubert, Jean Pastre, Julie Traclet, Sébastien Quetant, Sabrina Zeghmar, Laurent Bertoletti, Vincent Cottin

Publikováno v: Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)

Abstract Background Interstitial lung disease (ILD) and pulmonary hypertension (PH) represent the major causes of mortality in systemic sclerosis (SSc). Patients with systemic sclerosis and combined PH and ILD (SSc-PH-ILD) generally have a poor progn

Externí odkaz: https://doaj.org/article/6591d699c70f4e2499c33c45d0c5b4be

Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension.

Autor: Ségolène Turquier, Laure Huot, Medhi Lamkhioued, Fabien Subtil, Julie Traclet, Kais Ahmad, François Lestelle, Louis Chauvelot, Vincent Cottin, Jean-François Mornex

Publikováno v: PLoS ONE, Vol 19, Iss 5, p e0298727 (2024)

Cardiac output (CO) is one of the primary prognostic factors evaluated during the follow-up of patients treated for pulmonary hypertension (PH). It is recommended that it be measured using the thermodilution technique during right heart catheterizati

Externí odkaz: https://doaj.org/article/f60a5710bd4c424b8d5ff4a3248f67ff

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?

Autor: Lucile Sesé, Hilario Nunes, Vincent Cottin, Dominique Israel-Biet, Bruno Crestani, Stephanie Guillot-Dudoret, Jacques Cadranel, Benoit Wallaert, Abdellatif Tazi, Bernard Maître, Gregoire Prévot, Sylvain Marchand-Adam, Sandrine Hirschi, Sandra Dury, Violaine Giraud, Anne Gondouin, Philippe Bonniaud, Julie Traclet, Karine Juvin, Raphael Borie, Zohra Carton, Olivia Freynet, Thomas Gille, Carole Planès, Dominique Valeyre, Yurdagül Uzunhan

Publikováno v: Frontiers in Medicine, Vol 8 (2021)

Background: Idiopathic pulmonary fibrosis (IPF) is characterized by a male predominance. The aim of the study was to explore gender differences in a well-designed French multicentre prospective IPF cohort (COhorte FIbrose, COFI) with a 5-year follow-

Externí odkaz: https://doaj.org/article/77da8e079275450d857dd370176cc2a1

Sustained response to low-dose nifedipine in a patient with idiopathic pulmonary arterial hypertension

Autor: Mouhamad Nasser, Julie Traclet, Jean-François Mornex

Publikováno v: Lung India, Vol 35, Iss 4, Pp 358-360 (2018)

Externí odkaz: https://doaj.org/article/943d10ccdff24350b4b467e29b88c0f6

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Autor: Abdellatif Tazi, Aurélie Le Borgne-Krams, Marine Cachanado, Tabassome Simon, Sylvain Marchand-Adam, Morgane Didier, Lidwine Wemeau-Stervinou, Sandrine Hirschi, Frédéric Rivière, Arnaud Bourdin, François Lebargy, Stéphane Dominique, Aude Gibelin, Alexandre Chabrol, Tristan Dégot, Jacques Cadranel, Martine Reynaud-Gaubert, Marie-Pierre Debray, Sylvie Leroy, Frédéric Gagnadoux, Emmanuel Bergot, François-Xavier Blanc, Alexandra Rousseau, Raphael Borie, Pierre Yves Brillet, Guillaume Beltramo, Mallorie Kerjouan, Hilario Nunes, Olivia Freynet, Julie Traclet, Bruno Crestani, Anne-Sophie Gamez, Grégoire Prévot, Jean Pastré, Dominique Israel-Biet, Marie-Christine Dombret, Laurent Plantier, Cécile Chenivesse, Laurence Berard, Ana Nieves, Emmanuel Gomez, Dominique Valeyre, Stéphane Jouneau, Anne Gondouin, Elodie Blanchard, C. Launois, Nathalie Bautin, Jean-Marc Naccache, Vincent Cottin, Antoine Parrot, Philippe Bonniaud

Publikováno v: The Lancet Respiratory Medicine
The Lancet Respiratory Medicine, 2022, 10 (1), pp.26-34. ⟨10.1016/S2213-2600(21)00354-4⟩
The Lancet Respiratory Medicine, Elsevier, 2021, ⟨10.1016/S2213-2600(21)00354-4⟩

Summary Background The use of cyclophosphamide in patients with acute exacerbation of idiopathic pulmonary fibrosis (IPF) is unknown. Our study was designed to evaluate the efficacy and safety of four cyclophosphamide pulses in addition to high-dose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691aabc7559d1112b47b6efd1428d864
https://doi.org/10.1016/s2213-2600(21)00354-4